Aclarion
ACON | NASDAQ
$1.39
-$0.17 (-10.74%)
At close: Nov 16, 2026, 4:00 PM ET
$1.44
+$0.05 (+3.53%)
After-hours:
Nov 16, 2026, 7:57 PM ET
-10.74%
(1D)No price chart data available for 1D timeframe.
Rating
45.5
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #379/1021 (Top 37%)
Key Statistics
Market Data
Market Cap $4.01M
1D Range
1.35 1.57
52W Range
1.35 8.17
Valuation (TTM)
PE -0.25
PB 0.27
EV/EBITDA 1.01
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $7.50
Cash Flow
FCF Yield -224.3%
SBC Adj. FCF Yield -237.7%
SBC Impact -6.0%
Margins
Gross Margin -32.8%
Operating Margin -10789.2%
FCF Margin -9117.8%
Growth (CAGR)
Revenue 3Y | 5Y 5.4% |
11.1%
Dil EPS 3Y | 5Y 139.1% |
78.6%
FCF 3Y | 5Y -36.1% |
-18.6%
Returns
ROA -63.9%
ROE -62.9%
ROIC -71.8%
Financial Health
Net Cash
$14.19M
Current Ratio 14.17
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic ...
Sector Healthcare
Employees 11
IPO Date Apr 22, 2022
Website www.aclarion.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 5, 2026
EPS
-$0.94
Beat +18.26%
YoY:
+67.92% REV
$33.73K
Beat +6.89%
YoY:
+78.09%Next Earnings
Mar 17, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$7.50
Upside
+439.57%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove ACON